Contracts › 75A50123C00052
75A50123C00052: The Scope of Work for This Contract Includes the Development and Validation of Biotin As an in Vivo Labelling Agent for Red Blood Cells to Replace Chromium 51 As the Standard Fda-Approved Technology for Assessing the Lifespan of Rbcs in Circulation.
Awarded to Cincinnati Univ of by Office of Assistant Secretary for Preparedness and Response.
$8.4Mobligated
$8.4Mpotential value
30 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50123C00052 |
|---|---|
| Awardee | Cincinnati Univ of |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 611310 Colleges, Universities, and Professional Schools |
| PSC | Q701 Specialized Medical Support |
| Place of performance | OH |
| Offers received | 1 |
| Period of performance | 21 September 2023 to 30 September 2027 |
| Potential end | 30 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 611310 contracts · All expiring contracts · USASpending record